Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Thomas Dörner, Simon J. Bowman, Robert Fox, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, Guido Junge, Janice Woznicki, Monika Sopala, Alexandre Avrameas, Wen‐Lin Luo, Wolfgang Hueber
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Arthritis & Rheumatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet